Allyltriethoxysilane(3-Triethoxysilyl-1-propene), 95%, 10g

2-(2-Oxo-5-phenyl-2,3-dihydro-1,3,4-oxadiazol-3-yl)acetic acid, 95+%, 1g

(3R)-pyrrolidine-3-carboxylic acid hydrochloride, 95.0%, 1g

4-Bromo-1-chloro-2-(chloromethyl)benzene, 95.0%, 10g

5-alpha-cholestan-3beta-ol, min. 95%, 10 g, glass packaging

2-Methoxy-5-(prop-2-en-1-yl)pyridine, 95+%, 500mg

3-(Benzyloxy)-4-methylbenzoic acid, 95+%, 1g

ROTI®Sep 1077 human, 100 ml

1-(9H-Fluoren-9-yl)-3,12-dioxo-2,7,10,16,19-pentaoxa-4,13-diazahenicosan-21-oic acid, 97%, 250mg

(S)-(-)-Sulpiride>98.0%(HPLC)(T)5g

3-Amino-4-hydroxybenzoic acid hydrate, 98%, 10g

3-Chloro-5-nitropicolinic acid, 95.0%, 100mg

Inoculation loop, 2.45 mm 25 pcs